- CSR Summary Not Yet Available
- NCT01009177
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameBosentanProduct NameTRACLEER®Therapeutic AreaRespiratory Tract (Lung and Bronchial) DiseasesEnrollment80% Female37.5%% WhiteN/A
Product ClassEndothelin Receptor AntagonistSponsor Protocol NumberAC-052-281Data PartnerJohnson & JohnsonCondition StudiedNeoplasmsMean/Median Age (Years)60.5
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available